The short version
25 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Hydroxychloroquine Sulfate · HYDROXYCHLOROQUINE SULFATE 300 mg/1 · Tablet, Film Coated · Oral · ANI Pharmaceuticals, Inc.
NDC 70954-0805-10 · 100 TABLET, FILM COATED in 1 BOTTLE · NDA · View full market →
25 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| A-S Medication Solutions | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Amneal Pharmaceuticals NY LLC | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Aphena Pharma Solutions - Tennessee, LLC | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Bryant Ranch Prepack | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Cardinal Health 107, LLC | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| American Health Packaging | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| ANI Pharmaceuticals, Inc. | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| ANI Pharmaceuticals, Inc. | HYDROXYCHLOROQUINE SULFATE 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Asclemed USA, Inc. | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| AvPAK | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Coupler LLC | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddy's Laboratories Inc. | HYDROXYCHLOROQUINE SULFATE 400 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddy's Laboratories Inc. | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddy's Laboratories Inc. | HYDROXYCHLOROQUINE SULFATE 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddy's Laboratories Inc. | HYDROXYCHLOROQUINE SULFATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Ipca Laboratories Limited | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Laurus Labs Limited | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Major Pharmaceuticals | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| NCS HealthCare of KY, LLC dba Vangard Labs | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Northstar Rx LLC. | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| NuCare Pharmaceuticals, Inc. | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| NuCare Pharmaceuticals,Inc. | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Preferred Pharmaceuticals, Inc. | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Quallent Pharmaceuticals Health LLC | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Rising Pharma Holdings, Inc. | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Lifesciences Limited | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Pharmaceuticals USA Inc. | HYDROXYCHLOROQUINE SULFATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Sovuna — NDC 70954-0805-10," retrieved September 3, 2026, https://drugdashboards.com/drug/70954080510.
Free to cite with attribution — see how the data is put together.